Clinical Trials
2 trialsNCT07356466 2026-01-21
FUGES032
Fujian Medical University
Phase EARLY_PHASE1 Enrolling by invitation
NCT05171335 2022-09-21
Neoadjuvant Combination Therapy of Lenvatinib and TACE for Transplant-Eligible Large Hepatocellular Carcinoma Patients
The Methodist Hospital Research Institute
Phase 2 Enrolling by invitation